國(guó)家自然科學(xué)基金委優(yōu)秀青年
國(guó)家自然科學(xué)基金委重點(diǎn)國(guó)際合作研究項(xiàng)目
國(guó)家自然科學(xué)基金委面上項(xiàng)目
廣東省自然科學(xué)基金委杰出青年
廣東省重大新藥創(chuàng)制專項(xiàng)
廣東省應(yīng)用型科技研發(fā)專項(xiàng)資金項(xiàng)目
?
Journal of Hematology & Oncology學(xué)術(shù)期刊，編輯委員會(huì)委員
廣東省免疫學(xué)會(huì)血液免疫專業(yè)委員會(huì)，主任委員
廣東省轉(zhuǎn)化醫(yī)學(xué)學(xué)會(huì) 第一屆腫瘤學(xué)分會(huì)，副主任委員
中國(guó)實(shí)驗(yàn)血液學(xué)專業(yè)委員會(huì)-血液免疫學(xué)組，委員
中國(guó)研究型醫(yī)院學(xué)會(huì)細(xì)胞研究與細(xì)胞治療專業(yè)委員會(huì)，委員
中國(guó)專利優(yōu)秀獎(jiǎng)
新西蘭國(guó)際領(lǐng)軍人才獎(jiǎng)
廣東省科技領(lǐng)軍人才
廣東省科技進(jìn)步二等獎(jiǎng)
廣東省專利優(yōu)秀獎(jiǎng)
1.??? Li P#, Burke S, Wang J, Chen X, Ortiz M, Lee SC, Lu D, Campos L, Goulding D, Ng BL, Dougan G, Huntly B, Gottgens B, Jenkins NA, Copeland NG, Colucci F, Liu P. Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion. Science. 2010 Jul 2;329(5987):85-9.?
2.??? Jiang Z, Liao R, Lv J, Li S, Zheng D, Qin L, Wu D, Chen S, Long Y, Wu Q, Wang S, Lin S, Huang X, Tang Z, Shi P, Zhou H, Liu Q, Zhao R, Li Y, Jie Y, Wei W, Lai P, Du X, Cui S, Weinkove R, Liu P, Pei D, Yao Y, Li P*. IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells. Leukemia. 2020 Nov 9.
3.??? Lai Y, Weng J, Wei X, Qin L, Lai P, Zhao R, Jiang Z, Li B, Lin S, Wang S, Wu Q, Tang Z, Liu P, Pei D, Yao Y, Du X, Li P*. Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T Cells. Leukemia. 2018 Mar;32(3):801-808.
4.??? Lin S, Huang G, Cheng L, Li Z, Xiao Y, Deng Q, Jiang Y, Li B, Lin S, Wang S, Wu Q, Yao H, Cao S, Li Y, Liu P, Wei W, Pei D, Yao Y, Wen Z, Zhang X, Wu Y, Zhang Z, Cui S, Sun X, Qian X, Li P*. Establishment of peripheral blood mononuclear cell-derived humanized lung cancer mouse models for studying efficacy of PD-L1/PD-1 targeted immunotherapy. MAbs. 2018 Nov-Dec;10(8):1301-1311.
5.??? Zhao R, Cheng L, Jiang Z, Wei X, Li B, Wu Q, Wang S, Lin S, Long Y, Zhang X, Wu Y, Du X, Pei D, Liu P, Li Y, Cui S, Yao Y, Li P*. DNAX-activating protein 10 co-stimulation enhances the anti-tumor efficacy of chimeric antigen receptor T cells. Oncoimmunology. 2018 Nov 2;8(1):e1509173.
6.??? Ye W, Jiang Z, Li GX, Xiao Y, Lin S, Lai Y, Wang S, Li B, Jia B, Li Y, Huang ZL, Li J, Feng F, Li S, Yao H, Liu Z, Cao S, Xu L, Li Y, Wu D, Zeng L, Zhong M, Liu P, Wen ZS, Xu B, Yao Y, Pei D, Li P*. Quantitative evaluation of the immunodeficiency of a mouse strain by tumor engraftments. J Hematol Oncol. 2015 May 29;8:59.
7.??? Li W, Jiang Z, Li T, Wei X, Zheng Y, Wu D, Yang L, Chen S, Xu B, Zhong M, Jiang J, Hu Y, Su H, Zhang M, Huang X, Geng S, Weng J, Du X, Liu P, Li Y, Liu H, Yao Y, Li P*. Genome-wide analyses identify KLF4 as an important negative regulator in T-cell acute lymphoblastic leukemia through directly inhibiting T-cell associated genes. Mol Cancer. 2015 Feb 3;14:26.
8.??? Xiao Y, Jiang Z, Li Y, Ye W, Jia B, Zhang M, Xu Y, Wu D, Lai L, Chen Y, Chang Y, Huang X, Liu H, Qing G, Liu P, Li Y, Xu B, Zhong M, Yao Y, Pei D, Li P*. ANGPTL7 regulates the expansion and repopulation of human hematopoietic stem and progenitor cells. Haematologica. 2015 May;100(5):585-94.
